Showing results (251-260 of 520) with videos related to
Sort By:
Pageof 52
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 1, 1999
Multiple primary melanomaN Conrad, P Leis, I Orengo, et al.Cancer Treatment Reports|July 1, 1986
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancerM D Abeloff, S T Rosen, G D Luk, et al.Leukemia & Lymphoma|October 29, 2009
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer CenterChristiane Querfeld, Neha Mehta, Steven T Rosen, et al.Phytochemistry|January 1, 1997
Triterpenoid saponins from Aster lingulatusY Shao, C T Ho, C K Chin, et al.Journal of Hospital Medicine|October 26, 2017
The Enhanced Care Program: Impact of a Care Transition Program on 30-Day Hospital Readmissions for Patients Discharged From an Acute Care Facility to Skilled Nursing FacilitiesBradley T Rosen, Ronald J Halbert, Kelley Hart, et al.Journal of the American Chemical Society|October 13, 2006
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug releaseHaimei Chen, Robert C MacDonald, Shuyou Li, et al.American Journal of Clinical Pathology|March 1, 1991
The use of monoclonal antibody 44-3A6 in cell blocks in the diagnosis of lung carcinoma, carcinomas metastatic to lung and pleura, and pleural malignant mesotheliomaD V Spagnolo, D Whitaker, S Carrello, et al.Journal of the American Academy of Dermatology|July 1, 1993
Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2aE A Springer, T M Kuzel, D Variakojis, et al.The Journal of Investigative Dermatology|August 23, 2014
Identification of p38β as a therapeutic target for the treatment of Sézary syndromeMeghan Bliss-Moreau, Cristian Coarfa, Preethi H Gunaratne, et al.Blood|March 29, 2012
Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapySamuel K McBrayer, Javelin C Cheng, Seema Singhal, et al.Pageof 52